Evidence map›Paper›PMID 35498462›Full record

ArticleRSC advances2020

Synthesis of 1,3-diaryl-spiro[azetidine-2,3'-indoline]-2',4-diones

Vadim Filatov, Maksim Kukushkin, Juliana Kuznetsova, Dmitry Skvortsov, Viktor Tafeenko, Nikolay Zyk, Alexander Majouga, Elena Beloglazkina

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. ACS omega · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Vadim FilatovMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.ORCID https://orcid.org/0000-0003-2651-0941
Maksim KukushkinMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.
Juliana KuznetsovaMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.
Dmitry SkvortsovMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.ORCID https://orcid.org/0000-0001-8336-8596
Viktor TafeenkoMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.
Nikolay ZykMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.
Alexander MajougaMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.
Elena BeloglazkinaMoscow State University, Department of Chemistry Leninskie gory 1-3 Moscow 119991 Russia bel@org.chem.msu.ru.ORCID https://orcid.org/0000-0001-6796-8241
Lomonosov Moscow State University · RUNational University of Science and Technology · RUSkolkovo Institute of Science and Technology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new synthetic approach for realizing biologically relevant bis-aryl spiro[azetidine-2,3'-indoline]-2',4-diones was developed based on Staudinger ketene-imine cycloaddition through the one-pot reaction of substituted acetic acids and Schiff bases in the presence of oxalyl chloride and an organic base. A series of [azetidine-2,3'-indoline]-2',4-diones were synthesized using this method. For comparison, the same compounds were obtained using a known technique, where ketene is generated from pre-synthesized acyl chloride. It was shown that the use of oxalyl chloride for ketene generation in the one-pot reaction at room temperature allows for the reversal of the diastereoselectivity of spiro-lactam formation, unlike previously described procedures.

Identifiers

PMID35498462
PMCPMC9051608
OpenAlexW3014850730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.